JP2024517630A5 - - Google Patents

Info

Publication number
JP2024517630A5
JP2024517630A5 JP2023563942A JP2023563942A JP2024517630A5 JP 2024517630 A5 JP2024517630 A5 JP 2024517630A5 JP 2023563942 A JP2023563942 A JP 2023563942A JP 2023563942 A JP2023563942 A JP 2023563942A JP 2024517630 A5 JP2024517630 A5 JP 2024517630A5
Authority
JP
Japan
Prior art keywords
cells
seq
amino acid
tcr
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023563942A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024517630A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/025223 external-priority patent/WO2022225852A1/en
Publication of JP2024517630A publication Critical patent/JP2024517630A/ja
Publication of JP2024517630A5 publication Critical patent/JP2024517630A5/ja
Pending legal-status Critical Current

Links

JP2023563942A 2021-04-19 2022-04-18 Ｍｈｃクラスｉペプチドを含む方法および組成物 Pending JP2024517630A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163176477P 2021-04-19 2021-04-19
US63/176,477 2021-04-19
PCT/US2022/025223 WO2022225852A1 (en) 2021-04-19 2022-04-18 Methods and compositions comprising mhc class i peptides

Publications (2)

Publication Number Publication Date
JP2024517630A JP2024517630A (ja) 2024-04-23
JP2024517630A5 true JP2024517630A5 (enExample) 2025-08-19

Family

ID=83722630

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023563942A Pending JP2024517630A (ja) 2021-04-19 2022-04-18 Ｍｈｃクラスｉペプチドを含む方法および組成物

Country Status (11)

Country Link
US (1) US20240207406A1 (enExample)
EP (1) EP4326306A4 (enExample)
JP (1) JP2024517630A (enExample)
KR (1) KR20230172572A (enExample)
CN (1) CN117425665A (enExample)
AU (1) AU2022260281A1 (enExample)
BR (1) BR112023021806A2 (enExample)
CA (1) CA3217185A1 (enExample)
IL (1) IL307802A (enExample)
MX (1) MX2023012367A (enExample)
WO (1) WO2022225852A1 (enExample)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10335471B2 (en) * 2015-08-28 2019-07-02 Immatics Biotechnologies Gmbh Method for treating cancer with activated T cells
GB201515321D0 (en) * 2015-08-28 2015-10-14 Immatics Biotechnologies Gmbh Novel peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers

Similar Documents

Publication Publication Date Title
KR102618231B1 (ko) 변형된 만능성 줄기 세포, 및 제조 및 사용 방법
CN106074601B (zh) 用于细胞免疫治疗的方法和组合物
US20220096546A1 (en) Modified Cell Expansion and Uses Thereof
BR112021003305A2 (pt) métodos para produzir células que expressam receptor de antígeno quimérico
JP2019080568A (ja) 腫瘍抗原を直接認識するために組換えｔ細胞レセプターを使用するための組成物及び方法
JP2022513148A (ja) Ｔ細胞の改変
US20210100841A1 (en) Presenting cell and use thereof in cell therapy
JP2021509287A (ja) キメラ抗原受容体（ｃａｒ）またはトランスジェニックｔ細胞受容体（ｔｃｒ）の発現のためのウイルスベクターで細胞を形質導入するための方法
US20210060069A1 (en) Coupled redirected cells and uses thereof
US20210137983A1 (en) Nk cell expansion and uses thereof
US20210379149A1 (en) Increasing or Maintaining T-Cell Subpopulations in Adoptive T-Cell Therapy
JP2017522859A (ja) グリピカン３に特異的なｔ細胞受容体、及び肝細胞癌の免疫療法のためのその使用
JP2023513605A5 (enExample)
US12611450B2 (en) T cell receptors and methods of use thereof
JP2022554395A5 (enExample)
US20210024890A1 (en) Modulating t cell function and response
US20230201258A1 (en) Polyspecific Binding Molecules and their use in Cell Therapy
CN117925528A (zh) 具有增强记忆t细胞表型的修饰t细胞
EP3935175A1 (en) T cell receptors and methods of use thereof
JP2022506781A (ja) メソテリンを標的とする免疫療法
EP3892720A1 (en) Presenting cell and use thereof in cell therapy
JP2024517630A5 (enExample)
JP2024516542A5 (enExample)
JP2024526836A5 (enExample)
JP2022554349A5 (enExample)